Your browser doesn't support javascript.
loading
Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI).
Poletti, Barbara; Aiello, Edoardo Nicolò; Solca, Federica; Torre, Silvia; Carelli, Laura; Ferrucci, Roberta; Verde, Federico; Ticozzi, Nicola; Silani, Vincenzo.
Afiliação
  • Poletti B; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy. b.poletti@auxologico.it.
  • Aiello EN; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.
  • Solca F; PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Torre S; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.
  • Carelli L; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.
  • Ferrucci R; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.
  • Verde F; Aldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, International Medical School, University of Milan, Milano, Italy.
  • Ticozzi N; ASST Santi Paolo e Carlo, San Paolo University Hospital, Milano, Italy.
  • Silani V; IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.
Neurol Sci ; 44(3): 941-946, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36417015
BACKGROUND: This study aimed at providing diagnostic properties and normative cut-offs for the Italian ECAS Carer Interview (ECAS-CI). MATERIALS: N = 292 non-demented ALS patients and N = 107 healthy controls (HCs) underwent the ECAS-CI and the Frontal Behavioural Inventory (FBI). Two ECAS-CI measures were addressed: (1) the number of symptoms (NoS; range = 0-13) and (2) that of individual symptom clusters (SC; range = 0-6). Diagnostics were explored against an FBI score ≥ than the 95th percentile of the patients' distribution. RESULTS: Both the NoS and SC discriminated patient from HCs. High accuracy, sensitivity, and specificity were detected for both the NoS and SC; however, at variance with SC, the NoS showed better post-test features and did not overestimate the occurrence of behavioural changes. The ECAS-CI converged with the FBI and diverged from the cognitive section of the ECAS. DISCUSSION: The ECAS-CI is a suitable screener for behavioural changes in ALS patients, with the NoS being its best outcome measure (cut-off: ≥ 3).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Esclerose Lateral Amiotrófica Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Cognitivos / Esclerose Lateral Amiotrófica Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article